Skip to content

The attenuating effect of substance X on postprandial serum triglyceride level in healthy human subjects.

The attenuating effect of substance X on postprandial serum triglyceride level in healthy human subjects. - The attenuating effect of substance X on postprandial serum triglyceride level.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026170
Enrollment
40
Registered
2017-02-22
Start date
2017-02-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Placebo meal : control meal (a single time intake) -&gt
Test meal : control meal containing substance X (a single time intake) Test meal : control meal containing substance X (a single time intake) -&gt
Placebo meal : control meal (a single time intake)

Sponsors

Medical Corporation Hokubu-kai, Utsukushigaoka Hospital
Lead Sponsor
Clinical Support Corporation
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Healthy Japanese Subjects 2)Subjects whose fasting serum triglyceride levels are from 30 mg/dL less than 150 mg/dL.

Exclusion criteria

Exclusion criteria: 1)Subjects with medical history of severe disorders. 2)Subjects with surgical history of digestive system (except appendectomy). 3)Subjects with continuous medical treatment for chronic disease. 4)Subjects who self-judge that diarrhea is likely to occur when they eat high fat diets. 5)Subjects regularly using medicine, supplements and/or functional foods (including Food for Specified Health Uses [FOSHU]) that may affect the results of the study. 6)Subjects consciously ingesting high-fiber foods. 7)Subjects who drink alcohol a lot regularly. 8)Pregnant or have possibility to become pregnant during the study or lactating women. 9)Subjects who have donated over 200 mL of blood and/or blood component within the past month, or subjects who have donated over 400 mL of blood and/or blood component within the past three months. Furthermore, subjects who will be donation over 1200 mL of blood and/or blood component within the past year, when adding the planned blood smpling volume in this study. 10)Subjects who judged as unsuitable for this study by the principal investigator for any reasons.

Design outcomes

Primary

MeasureTime frame
Serum triglyceride (0-6 hrs)

Secondary

MeasureTime frame
Serum RLP-cholesterol (0-6 hrs)

Countries

Japan

Contacts

Public ContactYuki Ishida

Hayashibara CO., LTD. R & D Division, Development Unit

yuki.ishida@hb.nagase.co.jp086-276-3141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026